• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion.

作者信息

Berti Sergio, De Caterina Alberto R, Berger Ronald D

机构信息

Cardiology Unit, Fondazione Toscana Gabriele Monasterio, Massa, Italy.

Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

出版信息

JACC Case Rep. 2022 Jun 15;4(12):755-757. doi: 10.1016/j.jaccas.2022.04.015.

DOI:10.1016/j.jaccas.2022.04.015
PMID:35734530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9207943/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9207943/b9cafd118cb2/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9207943/b9cafd118cb2/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9207943/b9cafd118cb2/fx1.jpg

相似文献

1
Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion.在依鲁替尼诱导的出血性心包积液中，左心耳封堵术作为抗凝剂的替代方法
JACC Case Rep. 2022 Jun 15;4(12):755-757. doi: 10.1016/j.jaccas.2022.04.015.
2
Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion.左心耳封堵术作为伊布替尼所致出血性心包积液中抗凝剂的替代治疗方法
JACC Case Rep. 2022 Jun 15;4(12):751-754. doi: 10.1016/j.jaccas.2022.01.027.
3
Non hemorrhagic pericardial effusion from ibrutinib İn a patient without comorbidities.在一名无合并症患者中，依鲁替尼引起的非出血性心包积液
J Oncol Pharm Pract. 2022 Jun;28(4):972-974. doi: 10.1177/10781552211073885. Epub 2022 Jan 10.
4
Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.经皮左心耳封堵术用于房颤且有抗凝禁忌证患者的卒中预防
Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23.
5
A Case of Delayed Hemorrhagic Effusive-Constrictive Pericarditis After Left Atrial Appendage Occlusion Device Placement.一例左心耳封堵装置置入术后迟发性出血性渗出缩窄性心包炎病例
JACC Case Rep. 2019 Jun 19;1(1):27-31. doi: 10.1016/j.jaccas.2019.04.003. eCollection 2019 Jun.
6
Pericardial Effusion After Left Atrial Appendage Closure: Timing, Predictors, and Clinical Impact.左心耳封堵术后的心包积液：发生时间、预测因素和临床影响。
JACC Cardiovasc Interv. 2024 Jun 10;17(11):1295-1307. doi: 10.1016/j.jcin.2024.01.310. Epub 2024 May 22.
7
The Use of Novel Non-Vitamin K Antagonist Oral Anticoagulants Following Closure of the Left Atrial Appendage: Preliminary Results of Clinical Follow-Up.新型非维生素 K 拮抗剂口服抗凝剂在左心耳封堵术后的应用：临床随访的初步结果。
Drug Des Devel Ther. 2021 Mar 9;15:1067-1073. doi: 10.2147/DDDT.S293812. eCollection 2021.
8
Device-Sizing and Associated Complications With Left Atrial Appendage Occlusion: Findings From the NCDR LAAO Registry.左心耳封堵装置大小与相关并发症：来自 NCDR LAAO 注册研究的结果。
Circ Cardiovasc Interv. 2022 Dec;15(12):e012183. doi: 10.1161/CIRCINTERVENTIONS.122.012183. Epub 2022 Dec 6.
9
Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis.用于左心耳封堵的Amplatzer Amulet和Watchman 2.5的安全性与有效性：一项系统评价和荟萃分析。
Pacing Clin Electrophysiol. 2022 Oct;45(10):1237-1247. doi: 10.1111/pace.14576. Epub 2022 Sep 1.
10
A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation.经导管左心耳封堵术治疗非瓣膜性心房颤动患者疗效及安全性评估的荟萃分析
Medicine (Baltimore). 2016 Aug;95(31):e4382. doi: 10.1097/MD.0000000000004382.

引用本文的文献

1
Diagnosis and Management of Cardiovascular Effects of Bruton's Tyrosine Kinase Inhibitors.布鲁顿酪氨酸激酶抑制剂的心血管效应的诊断与管理。
Curr Cardiol Rep. 2023 Sep;25(9):941-958. doi: 10.1007/s11886-023-01916-4. Epub 2023 Jul 27.

本文引用的文献

1
Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion.左心耳封堵术作为伊布替尼所致出血性心包积液中抗凝剂的替代治疗方法
JACC Case Rep. 2022 Jun 15;4(12):751-754. doi: 10.1016/j.jaccas.2022.01.027.
2
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
3
Incidence, Characterization, and Clinical Impact of Device-Related Thrombus Following Left Atrial Appendage Occlusion in the Prospective Global AMPLATZER Amulet Observational Study.在前瞻性全球 AMPLATZER Amulet 观察研究中左心耳封堵术后器械相关血栓的发生率、特征及临床影响。
JACC Cardiovasc Interv. 2019 Jun 10;12(11):1003-1014. doi: 10.1016/j.jcin.2019.02.003. Epub 2019 May 15.
4
Ibrutinib-Associated Atrial Fibrillation.伊布替尼相关心房颤动。
JACC Clin Electrophysiol. 2018 Dec;4(12):1491-1500. doi: 10.1016/j.jacep.2018.06.004. Epub 2018 Aug 29.
5
Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib.接受依鲁替尼治疗的患者心房颤动的累积发病率、危险因素及管理
Blood Adv. 2017 Sep 8;1(20):1739-1748. doi: 10.1182/bloodadvances.2017009720. eCollection 2017 Sep 12.
6
Ibrutinib Inhibits Platelet Integrin αIIbβ3 Outside-In Signaling and Thrombus Stability But Not Adhesion to Collagen.依鲁替尼抑制血小板整合素 αIIbβ3 外向信号和血栓稳定性，但不抑制与胶原的黏附。
Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2326-35. doi: 10.1161/ATVBAHA.115.306130. Epub 2015 Sep 10.
7
Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug.用于心房颤动卒中预防的左心耳封堵术：使用AMPLATZER心脏封堵器的多中心经验
EuroIntervention. 2016 Feb;11(10):1170-9. doi: 10.4244/EIJY15M01_06.
8
Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.前瞻性随机评估 Watchman 左心耳封堵装置在房颤患者与长期华法林治疗中的效果：PREVAIL 试验。
J Am Coll Cardiol. 2014 Jul 8;64(1):1-12. doi: 10.1016/j.jacc.2014.04.029.
9
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组及心律学会的报告
J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76. doi: 10.1016/j.jacc.2014.03.022. Epub 2014 Mar 28.
10
Temporal relationship between subclinical atrial fibrillation and embolic events.无症状性心房颤动与栓塞事件之间的时间关系。
Circulation. 2014 May 27;129(21):2094-9. doi: 10.1161/CIRCULATIONAHA.113.007825. Epub 2014 Mar 14.